FIELD: biotechnology.
SUBSTANCE: invention relates to a method of obtaining multicomponent spheroids, including isolation of cells, growth of cell cultures, detachment from the substrate, centrifugation, resuspension, determination of concentration and viability, transfer to a culture medium with an ultra-low adhesive coating, removal of single cells, included in the composition of spheroids, the connection of a suspension of human stromal and immune cells and their introduction into a culture dish with an ultra-low adhesive coating, in which there are spheroids already formed from epithelial tumor and immune cells.
EFFECT: invention is effective for obtaining multicomponent three-dimensional cell constructs.
1 cl, 5 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING TISSUE-ENGINEERED IN VITRO MODEL OF HUMAN HEAD AND NECK SQUAMOUS CELL CARCINOMA | 2023 |
|
RU2825474C1 |
| METHOD FOR PRODUCING ORGANOIDS FROM TUMOUR TISSUE OF THE HEAD AND NECK | 2021 |
|
RU2787378C1 |
| METHOD FOR INCREASING THE PROLIFERATIVE POTENTIAL OF THREE-DIMENSIONAL TUMOR CELL CULTURES | 2021 |
|
RU2782600C1 |
| METHOD FOR SCREENING ANTITUMOUR PREPARATIONS IN VITRO ON A MULTICOMPONENT CELL TEST SYSTEM | 2018 |
|
RU2695568C1 |
| COMBINED GRAFT OF DERMAL MATRIX WITH MESENCHYMAL MULTIPOTENT STROMAL CELLS, METHOD FOR PREPARING IT AND METHOD FOR WOUND HEALING USING IT | 2013 |
|
RU2526813C1 |
| METHOD OF CO-CULTIVATING OF THREE-DIMENSIONAL CELL CULTURES OF HUMAN LOWER RESPIRATORY TRACT TO OBTAIN CELLULAR MODEL FOR IN VITRO STUDIES | 2023 |
|
RU2814138C1 |
| METHOD OF TREATING PATIENT'S ORAL DISEASES (VERSIONS) | 2007 |
|
RU2498808C9 |
| BIOCOMPOSITE SPHEROID FOR BONE REPAIR AND METHOD OF ITS PREPARATION | 2020 |
|
RU2744732C1 |
| OCCLUDER FOR TRANSCUTANEOUS TRANSLUMINAL PROCEDURE (VERSIONS), METHOD OF TRANSCUTANEOUS TRANSLUMINAL CLOSING OF HOLE IN HEART, METHOD OF ACTIVISATION OF MAMMALIAN TISSUE VASCULARISATION IN VIVO AND METHOD OF ACTIVISATION OF ANASTOMOSIS PLACE HEALING | 2007 |
|
RU2470611C2 |
| REPRODUCTION AND USE OF NON-HEMATOPOIETIC TISSUE-RESIDENT γδ T-CELLS | 2016 |
|
RU2784566C2 |
